Transarterial chemoembolization: modalities, indication, and patient selection.
about
Hepatocellular carcinoma: Where are we?Current status and perspectives of immune-based therapies for hepatocellular carcinomaMolecular imaging and therapy targeting copper metabolism in hepatocellular carcinomaCancer and liver cirrhosis: implications on prognosis and managementA nonrandomized cohort and a randomized study of local control of large hepatocarcinoma by targeting intratumoral lactic acidosisDegradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in Intrahepatic Cholangiocellular Carcinoma (ICC): Results from a National Multi-Center Study on Safety and EfficacyEvaluation of CT vascularization patterns for survival prognosis in patients with hepatocellular carcinoma treated by conventional TACE.Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma.Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysisNovel implications in the treatment of hepatocellular carcinoma.Advances in Local and Systemic Therapies for Hepatocellular Cancer.Postoperative adjuvant TACE for patients of hepatocellular carcinoma in AJCC stage I: friend or foe? a propensity score analysis.Experience from a real-life cohort: outcome of 606 patients with hepatocellular carcinoma following transarterial chemoembolization.Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinomaTransarterial chemoembolization with drug-eluting beads is effective for the maintenance of the Milan-in status in patients with a small hepatocellular carcinoma.Complete Remission after Sequential Therapy of Drug Eluting Beads Transarterial Chemoembolization and Liver Resection in Large Solitary Nodule Hepatocellular Carcinoma.Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma.Patterns and challenges of treatment sequencing in patients with hepatocellular carcinoma: Experience from a German referral center.Health-Related Quality of Life in Patients with Hepatocellular Carcinoma Treated with Initial Transarterial Chemoembolization.Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma.Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model.The status of transarterial chemoembolization treatment in the era of precision oncology.Switch to miriplatin for multinodular hepatocellular carcinoma unresponsive to transarterial chemoembolization with epirubicin: a prospective study.Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma.High expression of Parkin predicts easier recurrence of patients with adjuvant transarterial chemoembolization.Short-term efficacy of transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for hepatocellular carcinoma: comparison with conventional transarterial chemoembolization.In vitro study of physical properties of various embolization particles regarding morphology before, during and after catheter passage.Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic disease.miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression
P2860
Q26765182-697677A4-ED00-499D-91D2-0F184A2B3D5FQ26772326-7E4973BD-A857-45DF-BA00-6F24A24DB232Q26772332-5B048E01-C503-488F-BC1E-B1B703C0F4EFQ28068579-8852A555-B1B6-4F33-B8FA-06B3F012BF6AQ28831507-F42716DC-39E4-46E9-BB12-5ADB8B6C5AB0Q33439286-757C1734-0695-4591-B580-265650830AE8Q33620645-71E7CDF6-74D0-4F9C-9EE3-FBD74262C093Q33621522-6BD19E40-B342-4142-9BCB-5669CA091FAEQ33635033-CF46D09D-8009-4FCC-8DD4-45CC9180E32CQ37235913-B4D05592-6BBD-4E50-9D6E-3A0086CD3C7BQ37542835-14015CD2-C4ED-426E-9B31-F81FD3650570Q38697243-86E92F5A-E161-41E3-8FE0-6718FFABEC3DQ38810775-892D0F6D-316E-41B9-8B71-BF5F56343CDDQ40593373-73850FAA-963B-4A99-A174-8346228E9A7FQ41101572-F4745324-EB9A-4A90-9E57-939D858B6337Q41669686-2CFB8A0C-0A1D-4531-B029-4C63C426D867Q42706068-1BA799EB-A255-4C17-850B-BF8D203BED12Q47225007-9F5C3674-2154-4450-913C-C50BB025F32BQ47440581-C49D271A-2C72-48CA-B5D4-B2654DE90E03Q47877427-E7EE919F-B094-4A6A-B209-10AB64906631Q48155342-4D869321-4B10-4B4E-8FC5-3EF30F98604AQ48189816-2B900463-945A-4EC1-A205-5848FA9E5DFBQ49491370-F1FD7C63-577F-4F94-8963-7350F4D070F1Q49608357-B5B86B1C-B24A-4951-A328-6028DD7ABF28Q49796251-23399F3F-EE2F-427B-9574-2DD1F3A920EAQ50236833-BDFC4E86-6E80-4042-9801-C361E6DC09C8Q51811901-52C91644-5E39-4772-8804-50257A601EC5Q52975024-54D8B7E6-392A-4AF4-AB24-C5941A9D4523Q54965293-61BF947D-876D-4910-B56E-6CCAA701B133Q58784090-DC8459B2-796C-492A-ABF4-CC8DBA94DCAA
P2860
Transarterial chemoembolization: modalities, indication, and patient selection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Transarterial chemoembolization: modalities, indication, and patient selection.
@en
type
label
Transarterial chemoembolization: modalities, indication, and patient selection.
@en
prefLabel
Transarterial chemoembolization: modalities, indication, and patient selection.
@en
P1476
Transarterial chemoembolization: modalities, indication, and patient selection.
@en
P2093
Florian Hucke
Wolfgang Sieghart
P304
P356
10.1016/J.JHEP.2015.02.010
P577
2015-02-11T00:00:00Z